SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 290.41 |
| Enterprise Value ($M) | 188.10 |
| Book Value ($M) | 538.55 |
| Book Value / Share | 9.23 |
| Price / Book | 0.54 |
| NCAV ($M) | 321.23 |
| NCAV / Share | 5.51 |
| Price / NCAV | 0.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.37 |
| Current Ratio | 4.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 438.89 |
| Assets | 656.20 |
| Liabilities | 117.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 198.77 |
| Operating Income | -40.66 |
| Net Income | -18.90 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -15.76 |
| Cash from Investing | -17.43 |
| Cash from Financing | -0.15 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 8.10 | ||
| 13G/A | Renaissance Technologies Llc | 6.40 | 27.40 | |
| 13G/A | Vanguard Group Inc | 6.01 | -13.43 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,445 | 585,331 | 12.72 | |
| 133,756 | 647,960 | 20.64 | |
| 68,806 | 384,844 | 17.88 | |
| 152,793 | 562,056 | 27.18 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| URGN – UroGen Pharma Ltd. | VCEL – Vericel Corporation |
| VERA – Vera Therapeutics, Inc. | VRCA – Verrica Pharmaceuticals Inc. |
| WVE – Wave Life Sciences Ltd. |
Financial data and stock pages provided by
Fintel.io